Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Cipla
Queensland Health
QuintilesIMS
Chubb
McKesson
Chinese Patent Office
Harvard Business School
US Army

Generated: June 24, 2018

DrugPatentWatch Database Preview

Sucroferric oxyhydroxide - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for sucroferric oxyhydroxide and what is the scope of sucroferric oxyhydroxide patent protection?

Sucroferric oxyhydroxide
is the generic ingredient in one branded drug marketed by Vifor Fresenius and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sucroferric oxyhydroxide has seventy-two patent family members in thirty-eight countries.

There are two drug master file entries for sucroferric oxyhydroxide. One supplier is listed for this compound.
Summary for sucroferric oxyhydroxide
International Patents:72
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 2
Suppliers / Packagers: 1
Bulk Api Vendors: 1
Clinical Trials: 3
DailyMed Link:sucroferric oxyhydroxide at DailyMed
Synonyms for sucroferric oxyhydroxide
12001-35-3
12678-06-7
1418308-48-1
63530-05-2
Colliron I.V.
DB09146
EINECS 232-464-7
Encifer
Fe-back
Fe-lib
Feojectin
Ferijet
Ferosoft S
Ferplex SS
Ferric oxide, saccharated
Ferric saccharate ...iron oxide (mix.)
Ferrivenin
Ferrum Hausmann i.v.
FZ7NYF5N8L
Iron oxide, saccharated
Iron sucrose [USAN:USP:BAN]
Iron sugar
Iviron
Neo-ferrum
Proferrin
Saccharated ferric oxide
Saccharated iron
Saccharated iron oxide
Succharated ferric oxide
Succharated ferric oxide [USAN:JAN]
Sucrofer
Sucrose, iron complex
UNII-FZ7NYF5N8L
Velphoro
XI 921
XI-921

US Patents and Regulatory Information for sucroferric oxyhydroxide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vifor Fresenius VELPHORO sucroferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Vifor Fresenius VELPHORO sucroferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

Supplementary Protection Certificates for sucroferric oxyhydroxide

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB14/087 United Kingdom ➤ Try a Free Trial PRODUCT NAME: MIXTURE OF POLYNUCLEAR IRON(III)OXYHYDROXIDE, SUCROSE AND STARCHES; REGISTERED: UK EU/1/14/943/001 20140828; UK EU/1/14/943/002 20140828; UK EU/1/14/943/003 20140828; UK EU/1/14/943/004 20140828
C0018 France ➤ Try a Free Trial PRODUCT NAME: MELANGE D'OXYHYDROXYDE DE FER (III) POLYNUCLEAIRE,DE SACCHAROSE ET D'AMIDONS.; REGISTRATION NO/DATE: EU/1/14/943/001 20140826
2015 00007 Denmark ➤ Try a Free Trial PRODUCT NAME: BLANDING AF POLYNUKLEAERT JERN(III)-OXYHYDROXID, SUCROSE OG STIVELSE; REG. NO/DATE: EU/1/14/943/001-004 20140826
0868125/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: FERRIOXYHYDROXIDUM/SACCHARUM/AMYLA; REGISTRATION NO/DATE: SWISSMEDIC 62986 22.01.2015
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Healthtrust
Daiichi Sankyo
Express Scripts
Cipla
Merck
QuintilesIMS
Harvard Business School
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.